Navigation Links
DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Date:5/3/2012

CUPERTINO, Calif., May 3, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months ended March 31, 2012. Excluding the accelerated recognition of deferred revenue described below, DURECT's reported revenues would have been $5.8 million for the three months ended March 31, 2012 (as compared to $8.6 million for the same period in 2011) and reported net loss would have been $4.6 million for the three months ended March 31, 2012 (as compared to a net loss of $6.4 million for the same period in 2011).  Total revenues as reported under GAAP were $41.2 million and net income as reported under GAAP was $30.8 million for the three months ended March 31, 2012; these figures include the accelerated recognition of $35.4 million in deferred revenue associated with upfront fees previously received under terminated collaboration agreements.  This $35.4 million in revenue is non-recurring and has no cash flow impact for the quarter.

(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)At March 31, 2012, we had cash and investments of $26.4 million, compared to cash and investments of $30.8 million at December 31, 2011."This quarter was dominated by the POSIDUR™ clinical trial results and partnership terminations.  However, we continued to make progress with our development programs and we have recently reinforced the protection of our pipeline through 13 patent issuances and 2 patent allowances involving major and/or partnered programs that extend patent protection in large market jurisdictions to 2025 or beyond," stated James E. Brown, D.V.M., President and CEO of DURECT.  "In particular, we now have issued U.S. patents covering REMOXY® and our other ORADUR®-based opioid programs that extend to at least 2025 as well
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
2. DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call
3. DURECT to Participate in Upcoming Healthcare Conferences
4. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
5. DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
6. DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)
7. DURECT Corporation to Participate in Upcoming Healthcare Conferences
8. DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
9. DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call
10. DURECT to Present at the Jefferies Healthcare Conference
11. DURECT Announces Resignation of Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... 2015 Research and ... the "Elemental Analysis Market by Type (Organic, ... Application (Life Sciences, Food and Beverage Testing, Environment ... report to their offering. The ... types, technologies, and applications. By type, the market ...
(Date:7/7/2015)... and FREMONT, Calif. , July 7, ... South Korea and Velos, Inc. have entered into ... eResearch for cancer research nationally throughout South Korea ... The recent agreement signing was accompanied by a two day ... , South Korea.  National Cancer Center President ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
(Date:7/7/2015)... ... , ... Owners of Green Ladies Cleaning are very pleased to announce that ... honor can only be gained by votes from Madison Magazine readership. , The company ... methods they use daily. Having a home cleaned with all-natural products means that residents ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dermatologists from the Mount ... (AIF), identifying 18 possible melanomas and 46 potential non-melanoma skin cancers (basal cell ... , The Aspen Ideas Festival, which was held from June 25 through July ...
(Date:7/7/2015)... Dallas, TX (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable ... Panama vs. Haiti and the United States vs. Honduras at the Toyota Stadium. ... today, July 7th at Toyota Stadium. The tournament, being held on American soil, will ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June 29th ... that have emerged about Hillary Clinton. Two plastic surgeons consulted by the publication ... than she has in some time and speculate that she might have benefited ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers ... Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for ... who have sex with men (MSM) and transgender women, the groups at highest ...
Breaking Medicine News(10 mins):Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3
... negative (benign) MRI-guided vacuum assisted breast biopsy may not be ... Yale New Haven Hospital in Connecticut, included 144 patients with ... 36 months. The study found no malignancies on follow-up ... of the study. Two patients had suspicious findings at follow-up ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay News) ... that regardless of how "full" a person may feel, ... overeating when tempted by yummy foods. The study ... eight participants, and the authors acknowledge that their findings ...
... be a primary cause of uncontrollable tumor growth in some ... authors, findings run counter to widely accepted beliefs that genetic ... or low oxygen levels in cells, is proven to be ... for curing the malignant growth could change in significant ways, ...
... Researchers at Albert Einstein College of Medicine of ... that levels of certain related proteins found in blood are associated ... up to a decade or more later. The findings, published ... a new front in the war against diabetes. These ...
... HealthDay Reporter , THURSDAY, May 3 (HealthDay News) -- When ... inflammation, and during the first 10 years with the disease ... kidney problems. Because kidney inflammation (also called lupus nephritis) ... of Rheumatology has issued new guidelines for the screening and ...
... presentations that will be given by researchers from ... American Psychiatric Association (APA) annual meeting in Philadelphia ... Lawrence C. Kolb Professor and chairman of the ... and NewYork-Presbyterian Hospital/Columbia and director of the New ...
Cached Medicine News:Health News:Why You Overeat Even When You're Full 2Health News:Why You Overeat Even When You're Full 3Health News:Low oxygen levels could drive cancer growth 2Health News:Low oxygen levels could drive cancer growth 3Health News:Study identifies possible protective blood factors against Type 2 diabetes 2Health News:New Guidelines Issued for Severe Lupus 2Health News:New Guidelines Issued for Severe Lupus 3Health News:Columbia University Medical Center and NY-Presbyterian experts at APA meeting 2Health News:Columbia University Medical Center and NY-Presbyterian experts at APA meeting 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: